Evidence map›Paper›PMID 37424750›Full record

ArticleFrontiers in behavioral neuroscience2023

Molecular and long-term behavioral consequences of neonatal opioid exposure and withdrawal in mice.

Amelia D Dunn, Shivon A Robinson, Chiso Nwokafor, Molly Estill, Julia Ferrante, Li Shen, Crystal O Lemchi, Jordi Creus-Muncunill, Angie Ramirez, Juliet Mengaziol and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in behavioral neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
10.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Amelia D Dunn *Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Shivon A Robinson *Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Chiso Nwokafor *Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Molly EstillDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Julia FerranteDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Li ShenDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Crystal O LemchiDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Jordi Creus-MuncunillDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Angie RamirezDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Juliet MengaziolDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Julia K BrynildsenDepartment of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, United States.
Mark LeggasDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, United States.
Jamie HornDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, United States.
Michelle E EhrlichDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Julie A BlendyDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Icahn School of Medicine at Mount Sinai · USTranslational Therapeutics (United States) · USUniversity of Pennsylvania · USSt. Jude Children's Research Hospital · US

Funding

University of Pennsylvania Postdoctoral Opportunities in Research and TeachingK12GM081259 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Janis K. Burkhardt · 2007 to 2026
$20.1M
T32 Translational Addiction Research Fellowship ProgramT32DA028874 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI Julie A Blendy, Anna Rose Childress · 2010 to 2026
$5.0M
Neonatal Opioid Exposure and Withdrawal: Molecular and Behavioral ConsequencesR01DA047743 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BLENDY, JULIE A, EHRLICH, MICHELLE E · 2020 to 2024
$3.6M
COVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
Investigation of acute and long-term neuroimmune changes induced by early-life opioid exposure and withdrawalF31DA059211 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI FERRANTE, JULIA RENEE · 2023 to 2025
$134k
NIDA NIH HHS F31 DA059211NIDA NIH HHS R01 DA047743NIDA NIH HHS T32 DA028874NIGMS NIH HHS K12 GM081259NIH HHS S10 OD026880NIH HHS S10 OD030463
6 · The paper itself

Abstract

Introduction: Infants exposed to opioids Methods: To address these issues, we developed a mouse model of NOWS that includes gestational and post-natal morphine exposure that encompasses the developmental equivalent of all three human trimesters and assessed both behavior and transcriptome alterations. Results: Opioid exposure throughout all three human equivalent trimesters delayed developmental milestones and produced acute withdrawal phenotypes in mice reminiscent of those observed in infants. We also uncovered different patterns of gene expression depending on the duration and timing of opioid exposure (3-trimesters, Discussion: Despite marked withdrawal and delays in development, long-term deficits in behaviors typically associated with substance use disorders were modest. Remarkably, transcriptomic analysis revealed an enrichment for genes with altered expression in published datasets for Autism Spectrum Disorders, which correlate well with the deficits in social affiliation seen in our model. The number of differentially expressed genes between the NOWS and saline groups varied markedly based on exposure protocol and sex, but common pathways included synapse development, the GABAergic and myelin systems, and mitochondrial function.

Indexed as

behaviorbrain transcriptomemouseneonatalopioidwithdrawal

Identifiers

PMID37424750
PMCPMC10324024
OpenAlexW4381661320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.